Instrument Inactif

Communiqués Clinical Laserthermia Systems AB Swiss Exchange

Actions

CLSR.B

SE0002756130

Cours en clôture Swiss Exchange Autres places de cotation
- ^SEK	-

31/05	Clinical Laserthermia Systems va lever 59 millions de couronnes suédoises par le biais d'une émission de droits	MT
29/05	Clinical Laserthermia Systems AB (publ) annonce ses resultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue	20/06	AQ
CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million	20/06	AQ
CLS publishes prospectus in connection with forthcoming rights issue	10/06	AQ
Clinical Laserthermia Systems publishes annual report for 2023	07/06	AQ
BioStock: CLS' partner initiates full market release in the US	05/06	AQ
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024	05/06	AQ
CLS presents its new strategic direction in a Business Update Event on June 12	05/06	AQ
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S	04/06	AQ
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m	30/05	AQ
CLS publishes interim report January - March 2024	29/05	AQ
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024	27/05	AQ
BioStock: CLS revises strategy - increases focus on neurosurgery	24/05	AQ
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings	21/05	AQ
BioStock: CLS launches in France	15/05	AQ
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company	14/05	AQ
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators	30/04	AQ
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split	19/04	AQ
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB	12/04	AQ
BioStock: CLS makes progress in prostate cancer in Europe and the US	12/04	AQ
Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system	11/04	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Clinical Laserthermia Systems AB Swiss Exchange

Actions

CLSR.B

SE0002756130

Communiqués

Filtres